Sanjay Ramakrishnan
University of Oxford
H-index: 11
Europe-United Kingdom
Top articles of Sanjay Ramakrishnan
Multiple Event-time Analysis: A New Approach for Event Based Clinical Trials in Obstructive Airway Diseases
2024/5
Predicting Severe Asthma Attacks With Blood Eosinophils and Exhaled Nitric Oxide (FeNO): Initial Data Analysis for the ORACLE Patient-level Meta-analysis
2024/5
The Exacerbation, Not the Patient, Determines Chronic Obstructive Pulmonary Disease Exacerbation Care Seeking
2024/4
Sanjay Ramakrishnan
H-Index: 4
Trailblazing Clinical Trials in Asthma, COPD, Sleep Medicine, and Education and Clinical Practice in 2023
Chest
2024/1/1
Simon Couillard
H-Index: 7
Sanjay Ramakrishnan
H-Index: 4
How have we measured trial outcomes of asthma attack treatment? A systematic review
2024/1/1
Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled …
The Lancet Respiratory Medicine
2024/1/1
Sanjay Ramakrishnan
H-Index: 4
Mahdi Mahdi
H-Index: 6
Adam Jones
H-Index: 27
Christopher Davies
H-Index: 12
Mona Bafadhel
H-Index: 27
Coordinated nasal mucosa-mediated immunity accelerates recovery from COVID-19
ERJ Open Research
2024/1/1
Jonathan R Baker
H-Index: 9
Sanjay Ramakrishnan
H-Index: 4
Mahdi Mahdi
H-Index: 6
Peter J Barnes
H-Index: 95
Mona Bafadhel
H-Index: 27
P165 How best to measure asthma attacks? A methodological systematic review
2023/11/1
Building healthcare professionals consensus on non-pharmacological patient care priorities during hospitalisation and post-discharge phases following acute exacerbation of …
2023/9/9
Neil Greening
H-Index: 15
Sanjay Ramakrishnan
H-Index: 4
Nodal analysis determined nasal mucosal-associated mediators were associated with accelerated clinical recovery from SARS-CoV-2 infection
2023/9/9
Jonathan Baker
H-Index: 22
Sanjay Ramakrishnan
H-Index: 4
Mahdi Mahdi
H-Index: 6
Richard Russell
H-Index: 22
Mona Bafadhel
H-Index: 27
Prednisolone for COPD exacerbations: time for a rethink
2023/9/1
Sanjay Ramakrishnan
H-Index: 4
Patients’ acceptance of outcome and experience measurements during hospitalisation for COPD exacerbations: a CICERO Clinical Research Collaboration–European Lung Foundation …
ERJ Open Research
2023/7/1
Recovery of breakthrough asthma attacks treated with oral steroids while on monoclonal antibody therapy: protocol for a prospective observational study (BOOST)
JMIR Research Protocols
2023/6/23
Chronic obstructive pulmonary disease: 10 years of precision-guided success
The Lancet Respiratory Medicine
2023/3/1
Sanjay Ramakrishnan
H-Index: 4
Correction to Lancet Respir Med2023; published online Nov 1. https://doi. org/10.1016/S2213
Lancet
2023
European Respiratory Society International Congress 2021: highlights from best-abstract awardees
2019/2/1
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
Thorax
2022/2/1
Heterogeneity of IPF exacerbations
The Lancet Respiratory Medicine
2022/1/1
Sanjay Ramakrishnan
H-Index: 4
Mona Bafadhel
H-Index: 27
Maintenance Pulmonary Rehabilitation: Can We Keep the Good Times Rolling?
Chest
2022/12/1
Sanjay Ramakrishnan
H-Index: 4
T5 Point of care blood eosinophil guided oral prednisolone for COPD exacerbations: a multi-centre double blind randomised controlled trial (The STARR2 trial)
2022/11/1
Co-Authors
